GlaxoSmithKline’s (GSK) Nucala (mepolizumab) has been approved by the MHRA to treat adults with uncontrolled chronic ...
Patients who have comorbid COPD with heart failure and ischemic heart disease have increased health care resource use and higher mortality.
The MHRA has authorised GSK’s Nucala (mepolizumab) in the UK as an add‑on maintenance treatment for adults with uncontrolled ...
GSK has high hopes for Nucala thanks to its less frequent dosing – once a month, versus every other week for Dupixent – and ...
Following the January 2025 wildfires affecting Los Angeles, there was an increase in emergency encounters for certain diagnoses.
Pharma giant GSK has received regulatory approval in China for its Nucala treatment for adults with inadequately controlled ...
In recent years, demand for behavioral health care has spiked in Rhode Island. Butler is hoping to meet that demand with an ...
MySuncoast.com on MSN
Emergency physician reports atypical strain not covered by this year’s vaccine causing late season surge
SARASOTA, Fla. ( WWSB) - Sarasota Doctors’ Hospital has seen a 30% surge in influenza cases over the past two weeks compared ...
The approval is based on two placebo-controlled phase 3 studies, which showed mepolizumab significantly reduced the annualised rate of moderate/severe exacerbations and time to first moderate/severe ...
The holiday season may have wrapped up, but emergency rooms and urgent care centers across the CSRA are still seeing a steady ...
People using beclometasone inhalers for asthma or other health conditions may want to read up on the NHS guidance for the ...
North Carolina recorded 71 flu deaths last year, most in adults 65 and older. Emergency room visits and hospitalizations ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback